Herpes simplex encephalitis after receiving COVID-19 vaccine; A case report

Zahra Ebadi; Fereshteh Ghadiri; Elnaz Asadollahzade; Abdorreza Naser Moghadasi

doi:10.18502/fem.v6i4.10443

Zahra Ebadi Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Fereshteh Ghadiri Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Elnaz Asadollahzade Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Abdorreza Naser Moghadasi Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

DOI: https://doi.org/10.18502/fem.v6i4.10443

Keywords: Adverse Effects; BBV152 COVID-19 Vaccine; COVID-19; COVID-19 Vaccines; Encephalitis; Herpes Simplex; Vaccination

Abstract

Shortly after the onset of the coronavirus pandemic, different vaccines were developed to combat it. The vaccines had different mechanisms and triggered cellular and humoral immune responses against the virus. In addition to their positive effects, various side effects have been reported for them. They rarely cause severe complications. They can also rarely trigger latent infections. The present case report presents a patient who developed herpes simplex encephalitis after receiving the second dose of the Covaxin (BBV152).